TMCI:NASDAQ
Treace Medical Concepts, Inc
$4.49
arrow_downward
-0.88%(-0.040) 1D
$4.64
arrow_upward
+3.25% (+0.15)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$4.57
High
$4.68
Low
$4.46
Mkt. cap
292.01M
Avg. vol.
328.20K
Volume
344.76K
52-wk high
$7.30
52-wk low
$1.17
EPS
-$0.93
Beta
1.41
Shares outstanding
65.04M
No. of employees
450
Open
$4.57
High
$4.68
Low
$4.46
Mkt. cap
292.01M
Avg. vol.
328.20K
Volume
344.76K
52-wk high
$7.30
52-wk low
$1.17
EPS
-$0.93
Beta
1.41
Shares outstanding
65.04M
No. of employees
450
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 weeks ago
TMCI Q2 2026 Earnings: Loss Narrows More Than Expected, Driving Modest Share Gains - Earnings Surprise Stocks
CarePlus VietNam
·
2 months ago
TMCI Q1 2026 Earnings: EPS Beats Estimates Despite Narrower Loss - Earnings Whisper Number
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc